Pay in 4 interest-free payments of $23.75 Learn more
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9
Chemical Name: 1-[(2
an Effective Constituent of Ligustrum lucidum Ait
Comparison of population pharmacokinetics based on steady-state assumption versus electronically monitored adherence to lopinavir
which directly correlated with the observed inhibition of transport activity
TAK-285 Size:Solid 10 mg Chemical Name: 1-[(2TAK 285 is a novel dual erbB protein kinase inhibitor that specifically targets human epidermal growth factor receptor (EGFR) and HER2. Methods: TAK 285 is currently being developed by Takeda. TAK 285 was found to be well tolerate in Phase I trials. Absorption of TAK 285 was rapid after oral dosing, and plasma exposure at steady state increased in a dose proportional fashion for doses ranging from 50 to 300 mg b. i. d. A partial response was observed
US$ 29.99
US$ 320.00
US$ 31.55